Time of Disease-Modifying Antirheumatic Drug Start in Juvenile Idiopathic Arthritis and the Likelihood of a Drug-Free Remission in Young Adulthood.

Kirsten MindenGerd HorneffMartina NiewerthEva SeipeltMartin AringerPeer AriesIvan FoeldvariJohannes-Peter HaasAriane KleinStefanie TatsisKlaus TenbrockAngela ZinkJens Klotsche

Published in: Arthritis care & research (2020)

Early DMARD treatment is associated with better disease control and outcomes, which supports the concept of a "window of opportunity" for JIA.

Keyphrases

juvenile idiopathic arthritis
disease activity
rheumatoid arthritis
rheumatoid arthritis patients
systemic lupus erythematosus
depressive symptoms
adverse drug
drug induced
emergency department